Table 5 |
||||||
| Grade 3 and 4 adverse events associated with the induction chemotherapy | ||||||
| Toxicity | Level 0 | (%) | Level −1 | (%) | All patients | (%) |
| N = 12 | N = 6 | N =18 | ||||
| Hematologic | ||||||
| Neutropenia | 9 | (75) | 1 | (17) | 10 | (56) |
| Leukopenia | - | - | 1 | (17) | 1 | (6) |
| Anemia | 1 | (8) | - | - | 1 | (6) |
| Non-hematologic | ||||||
| Diarrhea | 1 | (8) | - | - | 1 | (6) |
| Dysphagia | 1 | (8) | - | - | 1 | (6) |
| Mucositis | 4 | (33) | 1 | (17) | 5 | (28) |
| Hyperkalemia | - | - | 1 | (17) | 1 | (6) |
| Hyponatremia | 1 | (8) | 1 | (17) | 2 | (11) |
| Renal failure | 1 | (8) | - | - | 1 | (6) |
Oertel et al. BMC Cancer 2012 12:483 doi:10.1186/1471-2407-12-483
